[NBIX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
02-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -166.57%
YoY- -130.74%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 21,947 9,357 10,569 11,267 11,110 41,634 12,157 47.99%
PBT 9,490 -3,078 -501 -886 1,331 31,382 1,976 183.30%
Tax -1,079 -884 -879 -906 -884 -1,167 -978 6.73%
NP 9,490 -3,078 -501 -886 1,331 31,382 1,976 183.30%
Tax Rate 11.37% - - - 66.42% 3.72% 49.49% -
Total Cost 12,457 12,435 11,070 12,153 9,779 10,252 10,181 14.32%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 43.24 -32.90 -4.74 -7.86 11.98 75.38 16.25 91.45%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS 0.14 -0.05 -0.01 -0.01 0.02 0.57 0.04 129.64%
EPS Diluted 0.14 -0.05 -0.01 -0.01 0.02 0.56 0.04 129.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.